Online Producer, New Delhi
Aditya's Feed
Sep 23, 2014

India withdraws regulator’s power to cap nonessential drug prices

NEW DELHI/MUMBAI, Sept 23 (Reuters) – India’s drug pricing
authority said the government has withdrawn its power to set
prices of nonessential medicines, but price caps on over 100
nonessential drugs that drew the industry’s ire in July will
remain.

The withdrawal, announced by the authority in a statement
late on Monday, is on a prospective basis and so does not affect
the July caps, a senior official at the National Pharmaceutical
Pricing Authority (NPPA) told Reuters on Tuesday.

Sep 22, 2014

India’s Mars mission a step closer to success with engine test

NEW DELHI (Reuters) – Indian scientists successfully tested the main engine of a spacecraft bound for Mars on Monday and performed a course correction that puts the low-cost project on track to enter the red planet’s orbit.

The $74-million mission will attempt to enter orbit around Mars early on Wednesday. If successful, it will be the first time a mission has entered Mars’ orbit on its first attempt, enhancing India’s position in the global space race.

Sep 19, 2014

Lizard in food sends 300 school children in Bangalore to hospital

NEW DELHI (Reuters) – About 300 pupils at a school were rushed to a hospital after consuming government-provided lunches, evoking memories of 23 children who died last year after eating food from the same welfare scheme.

A dead lizard was found in one of the seven food containers provided under the midday meal scheme at a government school in Bangalore, a teacher told Reuters.

Sep 19, 2014

Lizard in food sends 300 school children in India to hospital

NEW DELHI (Reuters) – About 300 pupils at an Indian school were rushed to a hospital after consuming government-provided lunches, evoking memories of 23 children who died last year after eating food from the same welfare scheme.

    A dead lizard was found in one of the seven food containers provided under India’s midday meal scheme at a government school in southern city of Bangalore, a teacher told Reuters.

Sep 19, 2014

India caps prices of 36 more drugs to improve access: government official

NEW DELHI/MUMBAI (Reuters) – India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country’s drug pricing authority told Reuters on Friday.

The medicines join a list of 348 drugs deemed essential and that are therefore subject to price caps, covering up to 30 percent of the total medication sold in a country where less than 20 percent of people are covered by health insurance.

Sep 19, 2014

India caps prices of 36 more drugs to improve access -govt official

NEW DELHI/MUMBAI, Sept 19 (Reuters) – India has capped the
prices of 36 drugs, including those used to treat infections and
diabetes, in its latest move to make essential medicines more
affordable, a senior official of the country’s drug pricing
authority told Reuters on Friday.

The medicines join the 348 drugs deemed essential and that
are therefore subject to price caps, covering up to 30 percent
of the total drugs sold in the country where less than 20
percent of its people are covered by health insurance.

Sep 18, 2014

Mars mission enters last lap; crucial test on Sept. 24

NEW DELHI (Reuters) – India’s first mission to Mars will attempt to put a spacecraft in orbit around the red planet next week, in a crucial test of a low-cost project carrying the country’s hopes to join the leaders of a global space race.

A successful outcome for the $74-million mission would stiffen Prime Minister Narendra Modi’s resolve to build new space launch facilities capable of handling heavier satellites, to make India a stronger player in the space technology market.

Sep 18, 2014

India’s Mars mission enters last lap; faces crucial test on September 24

NEW DELHI (Reuters) – India’s first mission to Mars will attempt to put a spacecraft in orbit around the red planet next week, in a crucial test of a low-cost project carrying the country’s hopes to join the leaders of a global space race.

A successful outcome for the $74-million mission would stiffen Prime Minister Narendra Modi’s resolve to build new space launch facilities capable of handling heavier satellites, to make India a stronger player in the space technology market.

Sep 15, 2014

Gilead licenses hepatitis C drug to Cipla, Ranbaxy, five others

NEW DELHI/MUMBAI (Reuters) – U.S. drugmaker Gilead Sciences Inc (GILD.O: Quote, Profile, Research) has agreed to license its hepatitis C drug Sovaldi to seven India-based drugmakers to sell cheaper versions of the $1,000-a-pill medicine in 91 developing nations including India.

Gilead also plans to launch its own branded Sovaldi in India at a price of $300 per month. The drug is normally given for either three or six months and it costs $84,000 for a 12-week course in the United States. Gilead’s next generation version its going to be even more expensive.

Sep 15, 2014

Gilead signs pact with 7 firms for cheap copies of hepatitis C drug

NEW DELHI/MUMBAI (Reuters) – U.S. drugmaker Gilead Sciences Inc has agreed to license its hepatitis C drug Sovaldi to seven India-based drugmakers to sell cheaper versions of the $1,000-a-pill medicine in 91 developing nations including India.

Gilead also plans to launch its own branded Sovaldi in India at a price of $300 per month. The drug is normally given for either three or six months and it costs $84,000 for a 12-week course in the United States. Gilead’s next generation version its going to be even more expensive.

    • About Aditya

      "Aditya is part of the India politics, economy and general news team at the Reuters bureau in New Delhi. After joining Reuters in July 2008, Aditya spent nearly six years managing content and writing for the Reuters.com India edition. During 2013-14, he was closely involved in developing the website's India Insight platform, writing on topics ranging from business and politics to stocks and mutual funds. Follow him on Twitter @adityakalra"
      Joined Reuters:
      July 2008
    • Contact Aditya

    • Follow Aditya